Allworth Financial’s Tenaya Therapeutics TNYA Stock Holding History

Allworth Financial’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-531	Closed	-$325	–	5045
2025 Q2	$325	Buy	+531	New	+$270	﹤0.01%	4229

Other funds holding TNYA

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Allworth Financial's TNYA Position: Q3 2025 in Review

Allworth Financial sold out of Tenaya Therapeutics (TNYA) in Q3 2025, closing a stake of 531 shares — an estimated $325 sold.

Allworth Financial first reported a position in TNYA in Q2 2025 and held it in 1 quarter. The position peaked at $325 in Q2 2025. 91 funds tracked by Wall St. Rank hold TNYA as of Q3 2025.

Allworth Financial reported no remaining Tenaya Therapeutics position as of Q3 2025 after selling out during the quarter.
Allworth Financial sold 531 Tenaya Therapeutics shares in Q3 2025, an estimated $325.
Allworth Financial first reported a position in Tenaya Therapeutics in Q2 2025 and held it in 1 quarter.
Allworth Financial's Tenaya Therapeutics position peaked at $325 in Q2 2025.
91 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2025.

Based on Allworth Financial's 13F filing for Q3 2025, filed 2 Dec 2025.